Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alena Gros

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Verapamil enhances the antitumoral efficacy of oncolytic adenovirusesAlena Gros, Cristina Puig, Sonia Guedan, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse modelsMeritxell Huch, Alena Gros, Anabel José, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanomaAlena Gros, Simon Turcotte, John R Wunderlich, et al.
Cancer Treatment Reviews|February 24, 2017
The expanding role of immunotherapyJuan Martin-Liberal, María Ochoa de Olza, Cinta Hierro, et al.
Nature Communications|January 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumorsVíctor Albarrán-Fernández, Laura Angelats, Julio Delgado, et al.
Cancer Research|November 1, 2008
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potencyAlena Gros, Jordi Martínez-Quintanilla, Cristina Puig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionMaria Parkhurst, Alena Gros, Anna Pasetto, et al.
Human Gene Therapy|June 23, 2009
Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targetingNeus Bayo-Puxan, Marta Gimenez-Alejandre, Sergio Lavilla-Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapySimon Turcotte, Alena Gros, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2013
Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapySimon Turcotte, Alena Gros, Katherine Hogan, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Verapamil enhances the antitumoral efficacy of oncolytic adenovirusesAlena Gros, Cristina Puig, Sonia Guedan, et al.
Neoplasia (New York, N.Y.)|June 2, 2009
Urokinase-type plasminogen activator receptor transcriptionally controlled adenoviruses eradicate pancreatic tumors and liver metastasis in mouse modelsMeritxell Huch, Alena Gros, Anabel José, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanomaAlena Gros, Simon Turcotte, John R Wunderlich, et al.
Cancer Treatment Reviews|February 24, 2017
The expanding role of immunotherapyJuan Martin-Liberal, María Ochoa de Olza, Cinta Hierro, et al.
Nature Communications|January 29, 2025
Unlocking the potential of engineered immune cell therapy for solid tumorsVíctor Albarrán-Fernández, Laura Angelats, Julio Delgado, et al.
Cancer Research|November 1, 2008
Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potencyAlena Gros, Jordi Martínez-Quintanilla, Cristina Puig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2016
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionMaria Parkhurst, Alena Gros, Anna Pasetto, et al.
Human Gene Therapy|June 23, 2009
Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targetingNeus Bayo-Puxan, Marta Gimenez-Alejandre, Sergio Lavilla-Alonso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Tumor-reactive CD8+ T cells in metastatic gastrointestinal cancer refractory to chemotherapySimon Turcotte, Alena Gros, Eric Tran, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2013
Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapySimon Turcotte, Alena Gros, Katherine Hogan, et al.
Pageof 5